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Recovery from heart attack, biomedicalisation and the production of a 
contingent health citizenship  
 
Abstract 
In this article I explore the experience of recovery from a heart attack through 
an analytic autoethnography. I discuss the tensions inherent in biomedical 
subjectivities of health and ill health during cardiac recovery through three key 
themes: (1) the transfer of responsibility and becoming a subject ‘at risk’, (2) 
technologies of biomedicine and the disciplining of subjectivities, and (3) the 
transformation of a body towards a new pharmaceuticalized bodily normal. 
Through an analysis driven by the biomedicalization thesis of Clarke, 
alongside work on biopower and the governmentality of health by Foucault, 
Rose and Rabinow, I seek to provide new insights into the process of cardiac 
recovery and the relationship between individual experience and broader 
socio-political processes.  Key to this analysis is a focus on the contingent 
subjectivities brought into being through biomedicalisation that constitute a 
new form of health citizenship that is otherwise not accounted for in narratives 
of recovery.  
 
Keywords: heart attack recovery; biomedicalisation; health citizenship; 
subjectivities of health and illness.  
 
Abstract word count: 150 
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Recovery from heart attack, biomedicalisation and the production of a 
contingent health citizenship 
 
Introduction 
I carry so many memories from my time on the cardiac ward but no 
coherent narrative. Instead, I am left with images and sensations of 
people and procedures, moments laden with emotion and vague 
flickers of the unknown and unknowable. I remember conversations 
with another man on the ward who became my most frequent 
interlocutor, probably because he was the closest in age though 
still some years my senior. We spoke of very little that was 
meaningful as that was the norm on the Ward but every exchange 
we had was laden with fear and anxiety. I could see it in his eyes, 
as he could in mine. Talk of the practicalities of when we might be 
able to leave and return to work became code for asking when – if 
ever – we would return to normal, when we would feel normal. I felt 
he knew, like me, that it was likely that neither of us would ever feel 
quite the same again. We were now different people, changed by 
our experience of a heart attack, always at risk whilst now 
apparently well once again1.  
 
                                                 
1 Inspired by the work of Frank (2013), and as suggested by one of the anonymous 
reviewers, I interrupt the academic narrative here and elsewhere with excerpts (in 
italics) from my autoethnographic journal in which I sought to describe my 
experience of recovering from a heart attack. I hope this (relatively minor) deviation 
from the traditional academic style of writing will serve to bring the academic and 
personal (autoethnographic) closer together and the topics being discussed into 
sharper focus.  
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Heart disease remains one of the major causes of death in the industrialised 
world, and continues to account for just under half of all deaths in the 
European Union (Nicols et al., 2013), in spite of repeated campaigns to 
reduce the incidence. Following the perceived difficulties of effecting 
meaningful lifestyle change in the general population, the focus has turned to 
secondary prevention amongst populations with a known risk (Wiles, 1998). 
An obvious and important indicator of risk is a cardiac event itself, with 
secondary prevention of heart disease following a heart attack an important 
worldwide strategy for public health (Wiles, 1998; Astin, Horrocks & Closs, 
2014). It is, therefore, crucial to continue efforts to gain a better understanding 
of the everyday experience of recovery from a heart attack if we hope to 
maximise the efficacy of this particular preventative strategy.  
 
There is a growing body of qualitative research that has sought to gain a 
better understanding of the process of recovery (see Astin, Horrocks & Closs, 
2014, for a recent review). This includes sociological research on patients’ 
perceptions and ‘lay’ epidemiology by Wiles (1998), work on embodiment and 
gender (e.g. Evans & Crust, 2015; Robertson, Sheikh & Moore, 2010), 
alongside the body of work from nursing and physiotherapy on a variety of 
therapeutic aspects of cardiac recovery care (e.g. Hanssen, Nordrehaug, Eide 
& Hanestad, 2009; O’Driscoll, Shave, Cushion, 2007; Salminen-Tuomaala, 
Astedt-Kurki, Rekiaro & Paavillainen, 2012). Astin et al. (2014) provides an 
excellent overview through their meta-ethnography of qualitative research on 
peoples’ experiences from 27 studies with over 500 participants (see also 
Galick, D’Arrigo-Patrick & Knudson-Martin, 2015, for a similar review focused 
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on women’s experiences of heart disease). They identify a number of key 
constructs about the experience of recovery from a cardiac event including: 
finding new limits and a life worth living; finding support for self; and finding a 
new normal. All participants experienced a change in their identity, moving 
from a sense of being in ‘familiar’ terrain to the ‘unfamiliar’, and all participants 
(as reported anyway) experienced a desire to get back to ‘normal’.   
 
Other work has focused on the implications of a heart attack for psychological 
issues, such as depression and anxiety, that themselves have an impact on 
long-term recovery, and health and well-being (Rosman, Whited, Lampert, 
Mosesso, Lawless & Sears, 2015). For instance, there is strong evidence for 
a higher incidence of anxiety and depression following a heart attack than 
amongst the general population (Wachelder, Moulaert, Van Heugten, Verbunt, 
Bekkers & Wade, 2009). Younger age, heart murmur, history of implantable 
cardioverter defibrillator (ICD) shock, and generalised anxiety all predict 
greater cardiac anxiety post cardiac arrest (Rosman et al. 2015) and may well 
be similarly predictive for people who have had a heart attack without arrest. 
The onset of depression and anxiety are not only problematic themselves for 
patients but are also predictive of poorer recovery and higher longer term 
risks for heart disease (Januzzi, Stern, Pasternak & DeSanctis, 2000).  
 
An image strikes me months later and returns me to my hospital 
bed. The image is of the catheter in my arm and the clear plastic 
patch over the incision made in my groin. Both featured heavily in 
my sense of connection to the machinery of the ward at the time. 
The catheter was actually mostly unnecessary and only remained 
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because the nursing staff were too busy to notice it was no longer 
needed. But it reassured me, offering instant access to my veins, 
and I missed it when it was removed. The clear patch that I was 
told to check for any hardening due to a blood clot acted to 
mobilise me as an agent of the hospital machine, responsible for 
my own care. I disliked this intensely as I wanted to be cared for, to 
be looked after by the expert hands of nurse and doctor, rather 
than needing to worry about my own health. I checked it 
repeatedly, in spite of nothing changing, with a continual and 
growing sense of health anxiety that endured long after leaving the 
hospital.  
 
Biomedicalisation 
A particularly valuable sociological framework within which to view recovery 
from heart attack experience is biomedicalisation (Clarke et al., 2003). 
Biomedicalisation refers to the continuing expansion of medicalization into 
new terrain as a result of relatively recent technoscientific change. This is not 
formulated as a simple replacement of medicalization with a new ideological 
system but as a contingent process in which ‘…workers and people as 
patients and as providers/health system workers are responding to and 
negotiating biomedicalization processes, attempting to shape new 
technoscientific innovations and organizational forms to meet their own 
needs.’ (Clarke et al., 2003: 166). Clarke et al., (2003) argue that this socio-
cultural shift involves five key (overlapping) processes: (1) growth of the 
Biomedical Technoservice Complex, Inc.; (2) a focus on health as much as 
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illness; (3) the increasingly technological nature of biomedicine; (4) 
transformation of information and distribution of knowledges; (5) 
transformation of bodies and identities. In brief, these are as follows.  
 
The first process draws on the notion of the ‘medical industrial complex’ to 
emphasise the power of the corporatized and privatized industry that is 
biomedicine. The second process involves the biomedicalization of health 
itself. As such, health has become an individual goal and site of moral 
responsibility that requires routine biomedical intervention. A consequence of 
this move is the growth of new risk and surveillance practices. The third 
process concerns the enormous growth in the technoscientific nature of 
biomedicine. This involves three overlapping areas ‘(1) Computerization and 
data banking; (2) molecularization and geneticization  of biomedicine and drug 
design; and (3) medical technology, design, development and distribution.’ 
(Ibid: 173). The fourth process concerns the growth and diversification of 
information about medical knowledges. The impact of the Internet here is well 
known, alongside other media reporting, but the outcomes are not simply the 
democratization of medical and health knowledges but something much more 
complex. The fifth and final process concerns the transformation of bodies 
themselves with a move from normalization to customization and the growth 
of new technoscientific identities that are grounded in a biomedicalized body.  
 
Within the context of biomedicalisation (Clarke et al., 2003; see also Flowers 
et al., 2013) there is, therefore, the production of new subjectivities concerned 
with health as much as illness. As such, new regimes of surveillance revolve 
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around discourses of prevention rather than cure, something that is central 
within discourses of heart attack recovery and secondary prevention. 
Biomedicalization involves no need for symptoms, as everyone is implicated 
in the process of eventually ‘becoming ill’. In other words, we all now occupy a 
liminal space between health and illness within a broader context of an 
individual moral obligation to resist illness through lifestyle and (sometimes) 
medical interventions. I argue below that this is particularly acute in the 
context of the ‘aggressive secondary prevention’ of heart disease that follows 
a heart attack, even when there is relatively little permanent damage to the 
heart. The maintenance of our health has become a new and highly intrusive 
‘moral obligation’ with a number of potentially unintended consequences, 
most notably health anxiety.  
 
As I eat my breakfast bran flakes a memory is triggered of my time 
recovering in the hospital ward. I recall my first breakfast in hospital 
vividly, with me hunting for the healthy option on the trolley of 
surprisingly unhealthy breakfast options. I remember my refusal of 
the sugar that was offered, which surprised the person serving me, 
and me gaining a liking for bran flakes stripped bare of any flavour, 
an attempt at healthy living that I clung to doggedly in the 
immediate aftermath of the heart attack. The experience of this 
breakfast continues to involve/evoke a curious blend of anxiety, 
control, fight, and sadness.  
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Biopower and the governmentality of health and well-being 
An important theoretical strand underpinning the biomedicalisation framework 
comes from Foucault, notably his concept of biopower and its role in 
producing new forms of governmentality (Foucault, 1978, 2003). As is now 
well known, Foucault contrasts biopower with classical sovereign power over 
individual life and death. It concerns the administration and control of human 
bodies and particularly the processes that optimise life, such that there 
emerges a new biopolitics of the population. Dean (1999: 99) describes it as 
follows: 
 
It is concerned with matters of life and death, with birth and 
propagation, with health and illness, both physical and mental, and 
with the processes that sustain or retard the optimisation of the life 
of the population. Bio-politics must then also concern the social, 
cultural, environmental, economic and geographical conditions 
under which humans live, procreate, become ill, maintain health or 
become healthy, and die.  
 
A variety of agencies, not least the state, serve to deploy biopower in the 
service of a biopolitics, and draw on the work of population level sciences 
(demography, epidemiology) to this end. Key to strategies of governmental 
control over the population is the way in which members of a population work 
on themselves to improve their own health and well-being. A central element 
of the ‘aggressive secondary prevention’ strategies for heart disease concerns 
the way that the heart attack survivor becomes implicated in taking 
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responsibility for their own medication and health regime regardless of 
individual need, something discussed further below.  
 
The work of Rose and Rabinow (Rabinow, 1996; Rose, 2001a, 2006; 
Rabinow and Rose, 2006; Rose and Novas, 2004) and the notions of  
‘molecularized biopower’, and ‘biosociality’ that they developed are also 
relevant here. In general, Rose and Rabinow seek to move the focus from 
governmentality of the population towards a more molecular (genetic) level 
and where we see a decline in the influence of the state and the growth of 
new forms of biological citizenship. Biosociality (Rabinow, 1996) refers to the 
ways in which individuals and communities might usefully identify themselves 
through reference to their biology in order to effect political power. This might 
include anything from resistance to pernicious strategies of ‘health’ to a 
coming together of people to claim recognition and rights. Whilst these 
theoretical concepts seek to advance and deepen our understanding of 
contemporary processes of biomedicalisation they arguably reduce biopower 
too readily to the molecular, with the risk that we then ignore continuing 
population level activity (Raman & Tutton, 2010). That is, whilst some fields of 
study (e.g. the new genetics that have arisen from mapping the human 
genome) are clearly best understood in terms of molecular rather than 
population level processes, there remain topics in which the (unreconstructed) 
ideas of Foucault about biopower may provide greater analytic purchase.  
 
This article aims to highlight key elements in the recovery from a heart attack 
that impact on health and well being over time. This aim includes discussion - 
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within the broader context of biomedicalisation - of the possible tensions that 
exist between subjectivities of health and ill-health amongst people with 
relatively minor heart damage that are encouraged to engage in ‘aggressive 
secondary prevention’. Key to this work is the use of an analytic 
autoethnography as the means by which to interrogate the value of 
biomedicalisation, alongside notions of biopower, the governmentality of 
health and the molecularization of life, as an explanatory framework.  
 
Methodology 
Autoethnography 
Autoethnography is gaining increased prominence as a method for gaining 
insight into the lived experience of health and illness. Autoethnography does, 
however, occupy a somewhat controversial place in the broader ethnographic 
tradition, particularly the evocative autoethnographic work following Ellis and 
Bochner (e.g. Ellis, 1991, 1995, 2004; Ellis & Bochner, 2000), and Denzin 
(1989, 1997). This work often appears as much like a literary text as mode of 
research, with a focus on ‘the confessional’ at the heart of the method. Within 
the context of the criticism of this approach to ethnographic research, 
Anderson (2006) sought to highlight a more analytic form of autoethnography 
that he argues naturally emerges from the long tradition of realist ethnography 
and contrasts in style and aim with the (predominantly postmodern) evocative 
autoethnography (see Denshire, 2014, for a recent overview of the field).  
 
Anderson (2006) argues that analytic autoethnography refers to research 
where a researcher is: (1) a full member of the research group or setting; (2) 
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visible as such a member in published texts; (3) committed to developing 
theoretical understandings of broader social phenomena. Beyond these three 
principles, he also outlines five key features that distinguish analytic auto-
ethnography from the more evocative forms. These include: (1) complete 
member researcher (CMR) status; (2) analytic reflexivity; (3) narrative visibility 
of the researcher’s self; (4) dialogue with informants beyond the self; (5) 
commitment to theoretical analysis. Considerable debate followed Anderson’s 
2006 article (e.g. Atkinson, 2006; Chang, 2016; Denzin, 2006; Ellis & 
Bockner, 2006), with some autoethnographers arguing that this need not be 
an either/or situation (e.g. Stanley, 2015; Weaver-Hightower, 2012; Williams & 
Kamal Jauhari bin Zaini, 2016). I share some sympathy with this view but 
focus primarily on the analytic in this article. Following Chang (2016), and her 
attempt to set standards for autoethnographic research, I think it is important 
to speak to broader sociocultural issues and engage with theory so that 
autoethnographic work can make a scholarly contribution to the literature.  
 
Tolich (2010) has raised a number of ethical challenges for autoethnography, 
particularly around consent when such accounts include information about 
other people (see also Chang, 2009, 2016). In many cases, consent is 
gathered retrospectively or not at all. In this article the extracts that are 
presented below contain minimal information about other people, only general 
discussion of the variety of health care professionals that I encountered, with 
any further identifying information removed entirely from the account. In this 
regard I have been alert to internal confidentiality, involving risk of disclosure 
of identifying information amongst colleagues, as well as external 
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confidentiality involving risk of identification to outsiders. The other ethical 
issue of particular relevance to autoethnography concerns risk to the 
researcher/author with self-disclosure. This is particularly significant for 
authors seeking to present highly sensitive and/or stigmatised material. In the 
present case that is not a particular risk given that: (i) this medical condition is 
not particularly stigmatising, and (ii) my medical history has already been 
widely shared with family, friends and colleagues, such that this poses 
minimal risk to myself either now or in the future.   
 
Findings 
On Saturday 13th April 2013 I experienced a heart attack that resulted in my 
hospitalisation and an emergency angioplasty. To be precise, I suffered an 
anterior ST-elevation myocardial infarct and underwent primary angioplasty in 
a large London hospital. The Left Anterior Descending Artery (LAD) – also 
known as ‘the widow maker’ due to the high risk of death with blockage to this 
artery - was tightly narrowed (95%) with thrombus and was stented (drug 
eluting) following thrombectomy. I was 43 years of age and otherwise in 
general good health. I am a white gay man in a long term relationship who 
would be classified as first generation middle class, a former smoker who is 
moderately overweight though otherwise fit and active. I have some distant 
family history of heart disease but none amongst immediate family. I had not 
suffered angina prior to the heart attack though had experienced some faints 
that prompted some heart investigation (ECG and blood tests) with nothing 
significant found. I stayed in hospital for 4 days. Before discharge I spoke with 
the cardiologist about the level of damage, which he said was ‘minor’ and a 
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hospital pharmacist about the medication that I was to take to prevent further 
heart attacks. The medication regime was as follows (od – once daily; bd – 
twice daily): Aspirin 75 mg od; Ticagrelor 90mg bd; Bisoprolol 5mg od; 
Ramipril 5 mg od; Atorvastatin 80mg od; Lansoprazole 30mg od; GTN spray 
as required. The bisoprolol and ramipril were due to be titrated up to 10mg od. 
This is a fairly typical diet of medication for people who have suffered a heart 
attack with only the anti-platelet Ticagrelor (to be taken for 12 months only) 
somewhat more unusual. A little over two years later and I now take the 
following: Aspirin 75 mg od; Bisoprolol 5mg od; Candesartan 2 mg od; 
Atorvastatin 80mg od; Lansoprazole 30mg od; GTN spray as required. The 
beta-blocker bisoprolol was titrated up but then dropped back down to 5mg od 
due to side effects (tiredness and laboured breathing). The ACE inhibitor (for 
blood pressure) ramipril was substituted with candesartan due to the common 
side effect of a dry cough.  
 
Terrified at my inability to breathe, I grabbed my GTN spray and 
pumped it repeatedly into my mouth. Overdoing it in the panic, I 
collapsed on the bed and frantically asked Ian to call an 
ambulance. Dread: I escaped death the first time but feared I will 
not do this time.  
 
I was readmitted on the 18th April following further symptoms similar to the 
initial heart attack. No acute changes were noted with the electrocardiogram 
(ECG), and my troponin level did not rise, so – following an exercise ECG - I 
was discharged the next day. On Friday 3rd May I began a six-week 
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programme of cardiac rehabilitation under the supervision of a cardiac 
physiotherapist in the same London hospital where I was previously treated. 
This consisted of discussion about lifestyle and a guided exercise programme 
in the hospital gym. Following discharge from hospital I sought out a private 
cardiologist to discuss what had happened to me and particularly my long-
term prognosis. I had a follow up ECG and echocardiogram and returned to 
work as Head of Department (HoD) and a private psychotherapist after 4 
months sick leave.  
 
As part of my psychological recovery, I undertook two separate 4-month 
periods of psychotherapy and documented my experience by writing a 
personal narrative account of the heart attack itself and the critical moments 
that followed. The documentary account of my experience of recovery forms 
the basis for the analysis that follows. The process of writing the documentary 
account of the experience was undoubtedly therapeutic in itself, as was the 
process of analysis. I should also note that I wrote this account prior to any 
examination of the extant literature and found my own experience very much 
reflective of the major themes in existing qualitative literature on this topic (as 
identified in Astin et al., 2014 for instance). The analysis below aims to 
provide greater depth of analytic insight into the psychosocial processes at 
stake across some key areas of biomedicalisation in operation in my 
experience of recovery from a heart attack. This includes: (1) The transfer of 
responsibility and becoming a subject ‘at risk’; (2) technologies of biomedicine 
and the disciplining of subjectivities; (3) the transformation of body towards a 
new bodily normal. The findings below are discussed in relation to the 
 15 
structural model of biomedicalisation, with the addition of further analysis 
through the theoretical lens of biopower and governmentality. 
 
(1) The transfer of responsibility and becoming a subject ‘at risk’ 
 
In common with the extant literature (e.g. Salminen-Tuomaala et al., 2012; 
Wiles, 1998) my experience of recovery shifted and changed over time. Most 
extant research is cross-sectional and includes patients within 12 months of 
hospital discharge (see Astin et al., 2014). Whilst some research on recovery 
has included patients with longer time periods from the cardiac event (e.g. 
Gambling, 2003; Gulanick, Billey, Perino & Keough, 1998) this has also been 
cross-sectional and not involved qualitatively examining the recovery process 
itself over a significant period of time for any individual participant. My 
experience spans three years from the cardiac event in April 2013 to the time 
of writing in May 2016. Over the course of these three years, it has become 
apparent that my ‘recovery’ was not to be a simple linear march of progress, a 
story of ‘getting better’ or a linear series of teleological ‘nows’ to healthy well-
being but rather something much more complex.  
 
Immediately following the heart attack I was able to comfortably and willingly 
adopt the sick role (Parsons, 1951; Williams, 2005), albeit only briefly. I 
remained in the intensive care unit for two days where I had nothing to do but 
eat, drink and ostensibly regain my health. With my sense of bodily security 
fundamentally undermined, it was ‘the machinery’ of the hospital that provided 
the security that I needed. This ranged from the technology of the ECG and 
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blood pressure monitors to the embodied practice of nurse and doctor. 
Moving to the cardiac ward began the process of returning me to the world 
and my sense of responsibility for self, with visits from family and friends, and 
flowers from work serving to pull me back into the present time, and place. 
Following discharge and the loss of the immediate safety of the hospital ward, 
the six weeks of cardiac rehabilitation kept me close to the hospital, with a 
continued sense of safety further reinforced through: (1) the variety of medical 
interventions: blood pressure measurement, blood tests, ECG, 
echocardiogram and so on, and (2) the social connections between myself, 
cardiac physiotherapist and other patients.  
 
I found myself epidemiologically constructed as a subject ‘at risk’ whilst in 
hospital by the cardiologist, and then later in relation with my general 
practitioner. This was powerfully invoked when the cardiologist asked me if 
there was a family history of heart disease. I replied that there was not and he 
immediately informed me that I must be wrong and that there must be a family 
(read: genetic) basis for heart disease at such a young age. This turn to the 
molecular (Rose, 2001a) with its attendant power led to a rapid trawl through 
my family history for evidence to fit the theory. An implicit bio-genetic 
personhood (Rose, 2001b) was brought into play in which there was no 
genetic testing but instead epidemiological evidence deployed to force me 
onto the Procrustean bed of a genetic basis for having a heart attack at such 
a young age. Not only this but I played my part in uncovering some (albeit 
minor) family history to provide evidence for this new subjectivity within my 
own narrative of becoming someone ‘at risk’.  
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Lay understandings of coronary heart disease played a role here in providing 
some resistance to the production of this new (and consequently, somewhat 
ambiguous) subjectivity (cf. Shim, 2010). In common with the extant literature 
(French, Senior, Weinman & Marteau, 2001), friends and family were quick to 
conclude that the cause of my heart attack must be due to lifestyle rather than 
genetics and - in particular - must due to stress. My stressful role as a Head of 
Department (HoD) was invoked time and time again as a primary causal 
factor, with many people suggesting that I should stand down from this role. 
These lay understandings contrasted markedly with medical opinion, with 
stress now considered much less important than the key unhealthy 
behaviours of smoking, poor diet and lack of exercise. The tension between 
these two regimes of power/knowledge (lay and medical) manifest itself in my 
decision to return to my role as HoD to finish my term (I had a year left in the 
role), and the difficulty of knowing whether this was ‘the right thing to do’. For 
me, not returning to my role as HoD meant that I was fundamentally and 
irrevocably changed – someone who is ‘ill’ – and unable to cope with such 
stressful situations now or in the future: ‘if I am healthy then I can carry on 
with my stressful job but if I am ill then perhaps I should slow down and 
disengage with such things’. Not returning to my role also meant closing down 
future possibilities. As a relatively young survivor of a heart attack, closing 
down future possibilities felt deeply depressive. My decision-making process 
was also undoubtedly inflected by a need to embrace a (traditionally 
masculine) ‘vibrant physicality’, as seen in other recovery stories (Robertson 
et al., 2010).   
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Biosociality  (Rabinow, 1996) was also relevant to the genetic construction of 
being ‘at risk’, with a coming together on the ward and during cardiac rehab 
with others sharing the same ‘biological susceptibility’ to heart disease. Whilst 
I was young amongst my biological peers, and our shared sociality only 
implicitly genetic, there was a sense of shared experience of now being ‘at 
risk’ and then later a shared purpose in the process of recovery, with those of 
us in cardiac rehab all seeking to return to work fundamentally unchanged (as 
academic, barrister and yoga teacher…). The weekly sessions served to 
maintain a biosocial space in which anxieties could be shared and motivation 
for the required biomedical self-governance developed. Rights claims were 
not formulated beyond the individual and a request for personalised insight 
into illness and recovery, as there are few claims that remain to be made with 
this ‘saturated’ disease category (Pollock, 2011). Regardless, this coming-
together allowed for the sharing of the latest thinking in the biomedicine of 
heart disease and both genetic and lifestyle factors in recovery.  
 
A sense of safety and accepting personal responsibility for future health did 
not increase with time, however, but actually decreased as the passing of time 
involved a growing distance from the safety of continual medical surveillance 
and biosociality. The end of cardiac rehabilitation marked a loss for me, a loss 
of regular access to expert and lay expertise that helped mediate the anxiety 
of emergent body sensations and change. This rapid - and not entirely 
consensual - transfer of responsibility left me carrying the burden of my 
(potentially precarious) health and well being without immediate biomedical 
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expertise or any sense of continuing biosociality, with no post-cardiac event 
community available to me.   
 
(2) Technologies of biomedicine and the disciplining of subjectivities 
 
Following the end of cardiac rehabilitation, confusion began to emerge for me 
about whether I was now someone who was healthy or ill. My cardiologist 
performed an echocardiogram some months after my heart attack to assess 
the level of damage and possible impact longer term. He turned the screen 
and showed me my pumping heart and pointed out the area where there was 
damage, mentioning that it was unlikely that an untrained eye would even 
notice it. But it could be seen and my heart was now damaged with the 
visualisation technology of modern cardiology meaning that I could see it 
myself. As Joyce (2010: 200) points out:  
 
Computer-based visualization technologies are crucial to the 
legitimisation and deployment of surgical, chemical, and lifestyle 
interventions and are part of the larger trend of biomedicalization 
that, as Clarke and her colleagues (2003, 181) rightly suggest, 
works “from the inside out.” 
 
This biomedical risk assessment technology served to bolster the (bio-
genetic) epidemiological construction of me being a subject ‘at risk’ in need of 
‘aggressive secondary prevention’ (Saukko, Farrimond, Evans & Qureshi, 
2012), albeit someone ‘lucky’ to have only minor heart damage and a positive 
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long-term prognosis.  And it was visualization that proved critical in framing 
my subjectivity within the context of biomedicalisation (Clarke et al., 2003) and 
the production of new subjectivities concerned with health as much as illness. 
This revolved around a governmental discourse of prevention that is central 
within discourses of heart attack recovery and secondary prevention. 
 
To further compound this new subjectivity came a post-heart attack diagnosis 
of hypercholesterolaemia in support of the long-term pharmaceuticalisation of 
subjectivity through the need for an aggressive ‘chemoprevention’ strategy 
(see Fosket, 2010 and Shim, 2002). I had only slightly high levels of 
cholesterol prior to the heart attack that were - at the time - being ‘treated’ 
through lifestyle intervention only. Following the heart attack these figures 
became glossed into a clinical diagnosis of hypercholesterolaemia in support 
of the desire to explain the heart attack incident occurring at an unusually 
young age and also to position me as a subject ‘at risk’ in need of long-term 
pharmaceutical intervention. Similarly, I was advised to take pills for reducing 
blood pressure in spite of having ‘normal’ blood pressure for they might have 
some ‘cardiac protective effect’. Is this about prevention of illness or rather the 
enhancement of health spoken of in the biomedicalisation thesis (Clarke et al., 
2003)? 
 
Central here is the notion of ‘adherence to treatment’, or what used to be 
called compliance, and sometimes also known as ‘concordance’ depending 
on the emphasis being placed upon patient agency (Kähkönen, Kankkunen, 
Saaranen, Miettinen, Kyngäs & Lamidi, 2015).  Motivation and responsibility 
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figure highly as predictive factors in adherence, along with other items like 
feeling a sense of normality, fear of complications and support from family and 
health care professionals (ibid). This is far from straightforward, however, with 
figures around 50% for adherence to drug and lifestyle regimes following a 
heart attack (ibid). There is evidence of a tension between biomedical regimes 
of recovery from heart attack (and its associated health governmentality) and 
individual experiences and strategies (Evans & Crust, 2015; Wiles, 1998; 
Robertson, Sheikh & Moore, 2010). In their study of older patients’ experience 
of cardiac rehabilitation, Evans & Crust (2015: 30) highlight the processual 
nature of rehabilitation and “changing ‘I’ identities”, with participants 
negotiating multiple – sometimes competing – embodied identities. There is 
an implied telos in this work, however, with the endpoint some notion of a 
return to health, as implied in the etymology of ‘recovery’ itself (c1300 
recoverie - return to health; a means of restoration; to get back). My own 
experience troubles the teleological end point of ‘health’ in ‘recovery’ from a 
heart attack for the biomedical construction of being a subject ‘at risk’ has no 
end point other than death. The biomedical triptych of (bio-genetic) 
epidemiology, visualisation technology (the echocardiogram) and the (post-
hoc) construction of clinically high cholesterol levels needing pharmaceutical 
intervention, all serve to produce a new ambiguous subjectivity in which 
health and illness become inextricably blurred.   
 
Adherence to aggressive secondary prevention involves not only serious 
lifestyle changes but also a new drug regime and continued medical 
surveillance. This tension between competing subjectivities of health and 
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illness has serious implications, such as a risk of anxiety through a perpetual 
ambiguity of the lifeworld (Merleau-Ponty, 1945/1962) that is problematic for 
long-term health and well-being (Januzzi, Stern, Pasternak & DeSanctis, 
2000).  
 
I am sat on the train to work, drinking my (decaf) coffee and 
thinking about the day’s activities in my diary. And I’m hit by the 
realisation that I have forgotten to take my pills (the proton pump 
inhibitor, the beta blocker and aspirin). I immediately panic and 
contact my partner, though I’m not sure why. Their presence 
reassures and I gather myself and talk myself into calm: ‘you will 
not die from missing some pills, you will be fine’.  
 
I wake with a start in the middle of night realising that I have 
forgotten to take my evening pills (statin and ace inhibitor). I 
chastise myself for forgetting and reach for the bedside drawer 
where the pills are kept.  
 
I am out walking with the dog, enjoying the sunshine on the 
Common, when I reach down to my pocket for my phone. I then 
realise that I’ve come out without my GTN spray and panic with the 
‘what if’ thoughts entering my head. I reassure myself but still end 
the walk quickly and head home, reassured there by the pressure 
of this (mostly never used) spray that has become my equivalent of 
the Disney Dumbo’s feather.  
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The pills that I take, along with the regular medical checks, form a figural 
backdrop (Elias, 1982, 1985) to how I feel about my recovery. I am reminded 
morning and night about the heart attack when I take my medication (see also 
Gregory, Bostock, Backett-Milburn, 2005). It is impossible to forget what 
happened: there is no space for closure here (see Figure 1 – The pill drawer). 
  
Insert Figure 1 about here – The pill drawer 
 
I must accept what has been lost (my sense of self before a heart attack), and 
incorporate the change into my present sense of identity, and embrace some 
sense of being a subject ‘at risk’ (or ill) even if antithetical to how I feel 
(Rosenbaum, 2015). A new story of self is now interwoven with being 
someone who has had a heart attack – mediated by biomedicine - and these 
two cannot be unbound. This is good for the governmental aims of the 
medical profession, of course, which requires people to take their pills and 
enact an active ‘health citizenship’ (Redden, 2002), taking personal 
responsibility for looking after themselves. But there is a tension, as I feel 
repeatedly drawn back to a traumatic moment, time and time again. I feel that 
I am changed now, in a liminal state of healthy but not healthy, ill but not ill. It 
is this ‘in-between’ that troubles, with me struggling to find solid ground: it is 
the ambiguity of the lifeworld (Merleau-Ponty, 1945/1962) that truly unsettles 
the telos of ‘being healthy’. Am I healthy now, just like everyone else who is 
‘well’, or am I sick in need of treatment? My pills feed this ambiguity as they 
are not strictly life preserving, but rather serve a longer-term 
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protective/enhancement role in preventing further heart attacks. And so do my 
encounters with the medical profession, where I am clearly changed in their 
perception, someone ‘at risk’ and in need of additional surveillance.  
 
(3) Transformation of bodies and a new ‘bodily normal’ 
 
In common with work on recovery from cancer, the extant literature on cardiac 
recovery speaks directly to the issue of people wanting to ‘find a new normal’ 
(Astin, Horrocks & Closs, 2014). The concept of ‘a new normal’ is 
complicated, however, as there are considerable variations in what this 
means. For many, this is not about ‘a new normal’ at all but rather about ‘a 
getting back to normal’, the apotheosis of the etymological basis of ‘recovery’ 
itself. For others, it is about creating a new normal in which new limits are 
understood and accepted, with lifestyle and medical regimes successfully 
incorporated into everyday life.  I discovered the notion of ‘a new normal’ 
spontaneously myself, having never before heard it deployed in the context of 
recovery from a heart attack, when I went to the gym having forgotten to take 
my morning pills.  
 
It was in many ways a very normal morning. I got up, ate breakfast 
and hauled myself to the gym. All felt as usual as I walked to the 
gym, got changed and got on a cross-trainer, my machine of 
choice. After a few minutes a trainer introduced himself to me and 
we chatted briefly. I started to feel slightly puffed out, which was 
unusual given I was only a few minutes in to the exercise. I 
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checked my heart rate on the machine and it was 126. My heart 
rate never gets to that level, except when pushed to the limit once 
by the cardiologist, as I am on beta-blockers to keep it low. I 
panicked slightly, packed up my things and headed home as fast 
as I could. I had clearly forgotten to take my morning pills. It was 
after taking the beta-blocker and feeling calmer that I realised that 
me on beta-blockers was my ‘new normal’. A heart rate of 126 in a 
gym is perfectly normal and would have been normal for me before 
the heart attack and pills designed to support ‘aggressive 
secondary prevention’. But no more, my ‘new normal’ is a medically 
enhanced normal where my heart rate almost never exceeds 115. I 
felt a curious sense of being changed, being ill but not ill.   
 
This ‘new normal’ is anything but ‘a getting back to normal’. Instead, it 
represents a very concrete example of the impact of biomedicalisation and the 
production of new embodied pharmaceuticalized subjectivity. My ‘new normal’ 
is founded on a sense of my body being fundamentally changed, slowed 
down, though not by the heart attack itself but rather the medication deployed 
to facilitate the ‘aggressive secondary prevention’ deemed necessary by 
biomedical epidemiology, visualization technology and my clinical state of 
being ‘at risk’. The technoscientific subjectivity of ‘someone with - or at risk 
from - heart disease’ has been created through technological advances in 
measurement and monitoring, with the necessary treatment itself further 
reinforcing this sense of subjectivity. It is reinforced in the most profound way 
by fundamentally altering the way a body feels, and therefore profoundly 
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altering a person’s sense of subjectivity given our bodies are the ‘vehicle of 
our being in the world’ (Merleau-Ponty, 1945/1962), and a primary means of 
learning (Benoot & Bilsen, 2016).  
 
Conclusions 
This article has sought to explore the process of recovery from a heart attack 
through the lens of the contemporary biomedicalisation of life. There was no 
simple process of ‘getting back to normal’ and no obvious end-point for 
recovery but instead a shifting figural landscape in this account, with the 
consequences to health and well being that follow (Januzzi et al., 2000). The 
construction of new – and competing – biomedical subjectivities emerged that 
are relevant to the long-term adoption of healthy behaviours and a new form 
of health citizenship. Whilst the need to ‘find a new normal’ has been 
identified in the extant literature (see Astin, Horrocks & Closs, 2014), I 
highlight a more nuanced account of the challenge in finding a way to live with 
the tension between health and ill-health. For whilst embracing ill health may 
result in a more active health citizenship, and greater (internalised) individual 
responsibility for the self-management of one’s medical regime and lifestyle, 
this has a potential cost in the form of increased anxiety from the ambiguity 
inherent in this liminal state. It is here that we may need to encourage the 
telling of new stories that provide alternatives to the traditional ‘restitution 
narrative’ of recovery (Frank, 2003), such that we find new ways of managing 
this tension.  
 
 27 
Frank (2003) identifies three key narrative forms that underpin the telling of 
stories of ill-health: stories of restitution, chaos and quest. Stories of restitution 
constitute the classic recovery narrative driven by contemporary medicine in 
which we see a move from health to ill-health (the moment of chaos) and back 
again. My experience of an emergency angioplasty might otherwise fall into 
this narrative form, with me readily able to narrate a story involving a ‘return to 
normal’ but for the new health citizenship that stems from the advance of 
biomedicalisation being described here. The demand for greater personal 
responsibility in reducing ‘risk’, allied to ongoing medical intervention and 
monitoring, and a change to the materiality of the body itself that is inherent in 
contemporary health citizenship suggests the need for a new narrative form. It 
appears we need to define a new category of narrative, one of ‘health 
citizenship’, in which the person is ill but not ill, well but not well, having to live 
out a new contingent subjectivity in which they are perpetually ‘at risk’ and 
subject to a growing regime of pharmaceuticalization. This narrative may 
currently sit alongside the story of restitution, as there is still space for simple 
medical stories of cure, but may in time replace it completely as 
biomedicalisation embeds itself ever deeper within our cultures through 
greater deployment of epidemiology, visualisation technologies and 
pharmaceuticalization.  
 
This study speaks to the growing work on embodiment and health in the 
context of cardiac rehabilitation (e.g. Evans & Crust, 2015; Robertson et al., 
2010). It builds on the extant work by highlighting a number of ways that 
existing stories of recovery (e.g. around ‘the new normal’) may manifest 
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themselves in a distinctly embodied manner. It is not the illness, in this 
particular case, which disturbs one’s existing bodily equilibrium but rather the 
impact of the drugs associated with the ‘aggressive secondary prevention’ of 
another cardiac event. Here, we see a new pharmaceutical body-subject in 
action through the creation of a technoscientific identity as ‘someone at risk of 
heart disease’.  
 
It is necessary to recognise the limitations of this work however. My position 
as a relatively young man undoubtedly colours my experience, with greater 
likelihood for anxiety (Oranta et al., 2011) and a distinct masculine experience 
(Robertson et al., 2010). That is, in spite of my avowed resistance to 
hegemonic masculinity (Connell, 1995) in my own presentation as a man, it 
remains highly likely that my developmental context has coloured my own 
experience of illness. The relatively limited damage to my heart is also 
significant in framing this particular account of the recovery experience. 
People with more serious damage and the potential for disability from a 
serious cardiac event will likely provide very different accounts of the temporal 
process of recovery (see Wiles, 1998). All this being said, it is worth noting 
that the emergent themes are resonant with the broader extant literature. The 
similarity of experience at a general level offers considerable reassurance that 
this is not simply an idiosyncratic account but instead a deepening in our 
understanding of a more generalised process of biomedicalisation, a process 
that has profound implications for the experience of ‘recovery’ from illness as 
a consequence of the disciplinary demands of a new health citizenship.   
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